For instance, Murakami et al. suggested that the prognosis of gastric cancer patients without p-Akt expression was always better than p-Akt positive ones, and the 5-year survival rates were 68% and 35% for patients with T3 or T4 stage tumors, respectively [16]. Here, AKT1 is linked to gastric cancer.